Episode 47 - Cancer Clinical Trial Breakthrough: Dual-Targeted CAR-T Cell Therapy

Published: March 19, 2018, 2:38 p.m.

It's a new cancer treatment that genetically alters a person's immune system, training healthy cells to target and kill deadly cancer cells. On today show, hear from the team of doctors who worked collaboratively in translating basic science research into successful clinical application. And later, hear from the Wisconsin man whose life has been extended after becoming the first person in the world to receive this groundbreaking treatment in a clinical trial. Learn about the success of Dual-Target CAR-T cell therapy, inside this edition of CTSI Discovery Radio!